Cargando…
Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial
Human parvovirus B19 (B19V) is the predominant virus currently detected in endomyocardial biopsies (EMBs). Recent findings indicate that, specifically, transcriptionally active B19V with detectable viral RNA is of prognostic relevance in inflammatory viral cardiomyopathy. We aimed to evaluate B19V r...
Autores principales: | Schultheiss, Heinz-Peter, Bock, Claus-Thomas, Aleshcheva, Ganna, Baumeier, Christian, Poller, Wolfgang, Escher, Felicitas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875228/ https://www.ncbi.nlm.nih.gov/pubmed/35216037 http://dx.doi.org/10.3390/v14020444 |
Ejemplares similares
-
Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2021) -
Viral Myocarditis—From Pathophysiology to Treatment
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2021) -
Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2021) -
Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure
por: Pietsch, Heiko, et al.
Publicado: (2020) -
MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy
por: Aleshcheva, Ganna, et al.
Publicado: (2023)